Drug manufacturer Bausch Health blindsided 340B covered entities on New Year’s Eve, announcing that starting the very next day, Jan. 1, more than 200 of its branded products and future branded products would no longer be available through distributor AmerisourceBergen “for 340B covered entities and 340B contract pharmacies for purchases at the 340B ceiling price.”
“Consequently, covered entities and contract pharmacies looking to obtain Bausch Health drugs at the 340B ceiling price through Amerisource Bergen should instead utilize an alternative national distributor or a regional distributor for such purchases,” Bausch Health said in an electronic communication dated Dec. 31 that multiple recipients shared with 340B Report.
Drug manufacturer Bausch Health blindsided 340B covered entities on New Year’s Eve, announcing that starting the very next day, Jan. 1, more than 200 of its branded products and future branded products would no longer be available through distributor AmerisourceBergen “for 340B covered entities and 340B contract pharmacies for purchases at the 340B ceiling price.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
